AstraZeneca

Financial Performance Investment Vaccine Development Research and Development Costs Technology Advancements Growth Strategy Innovation Merger Vaccine Work Market Strategy Production Revenue Growth New Medicines Products Corporate Strategy Acquisition US Market Investment Decisions Vaccine Withdrawal Expansion Investments

9 ARTICLES

9mo ago

AstraZeneca H1 Revenue Jumps 11% as It Pledges $50 Billion U.S. Expansion

Robust double-digit profit growth spurred a reassessment of a U.S. primary listing to strengthen its presence in the world’s largest biopharmaceutical market.